07/16/2025
6:20 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
10:51 AM | Allarity Therapeutics (Issuer)
Ervin Jeffrey S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
7:43 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
7:07 AM | Allarity Therapeutics (Filer)
| Form RW | |
06/11/2025
3:10 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
7:09 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:05 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
4:27 PM | Allarity Therapeutics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for ALLR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/30/2025
4:28 PM | Allarity Therapeutics (Filer)
| Form DEFA14A | |
04/28/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
7:06 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
6:55 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
7:07 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4/A | |
01/24/2025
7:09 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4/A | |
01/24/2025
7:10 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4/A | |
01/24/2025
3:12 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:13 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:14 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:16 PM | Allarity Therapeutics (Issuer)
Jensen Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:17 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:18 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:24 PM | 3i, LP (Filed by)
Allarity Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:32 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:34 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:05 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
7:53 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
09/10/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 8-K/A | |
09/09/2024
8:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
4:57 PM | Allarity Therapeutics (Subject)
Olmsted Investments LLC (Filed by)
| Form SCHEDULE 13G | |
08/21/2024
3:55 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
